2023•Unpublished venueOpen access

Supplementary Figure S23 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition

Matti Annala, Sinja Taavitsainen, Daniel Khalaf, Gillian Vandekerkhove, Kevin Beja, Joonatan Sipola, Evan W. Warner, Cameron Herberts, Amanda Wong, Simon Fu, Daygen L. Finch, Conrad D. Oja, Joanna Vergidis, Muhammad Zulfiqar, Bernhard J. Eigl, Christian K. Kollmansberger, Matti Nykter, Martin Gleave, Kim N., Alexander W. Wyatt

Open full text 0 citations

Abstract

Supplementary Figure S23 provides AR region copy number profiles for all 20 patients that showed a change in the structure of androgen receptor (AR) amplifications after treatment with abiraterone/enzalutamide

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Enzalutamide, Androgen receptor, Prostate cancer, Abiraterone, Androgen, Internal medicine, Cancer research, Biology